Plus   Neg

Stock Alert: Genetic Technologies Surges 65%

Shares Genetic Technologies Ltd. (GENE) are currently surging over 65% after the molecular diagnostics company provided update on its COVID-19 PRS test.

GENE is currently trading at $7.15, up $2.85 or 66.28%, on the Nasdaq.

The company said total COVID-19 positive patient data analyzed exceeds 5,500 following inclusion of further 4,000 patients' data. Analysis confirms that the test is well calibrated.

Genetic Technologies anticipates submission for regulatory clearance via Centers for Medicare and Medicaid Services/Clinical Laboratory Improvement Amendments by the end of first quarter 2021 following final validation process of expanded dataset.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
South Korea's Hyundai Motor Co. announced its decision to suspend production at its Asan plant for two days starting on Monday due to a chip shortage amid the pandemic crisis, Reuters reported. The company is experiencing trouble in supply conditions for semiconductor parts for powertrain control units. The Asan factory manufactures 300,000 vehicles, including the Sonata and Grandeur sedans, each The U.S. Department of Health and Human Services is set to expand its Health Center COVID-19 Vaccine Program to include all HRSA-funded health centers. This will increase the total number of health centers that have been invited to join the program to 1,470 nationwide from the earlier 950. McDonald's Corp. is planning to hire 25,000 workers in its restaurants across Texas in April, reports said. In a three-day event from April 13 to 15, the fast-food chain is expected to hire for crew and management positions. During these hiring days, participating McDonald's restaurants in the state will be accepting applications and interviewing job seekers.
Follow RTT